Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00234988 · ClinicalTrials.gov registry record · Phase 4
A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.
A Phase 4 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 4
- Development phase
- 93
- Enrollment target
NCT00234988 is a Phase 4 study that has completed, run by Abbott. The registered enrollment target is 93 participants.
The verdict
NCT00234988, a Phase 4 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 93 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the safety and weight loss when sibutramine is used in overweight and obese subjects.
Interventions
- DRUG sibutramine hydochloride monohydrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2004-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00234988
The ClinicalTrials.gov registry entry for NCT00234988 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which sibutramine hydochloride monohydrate is the first listed.
NCT00234988 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00234988 about?
NCT00234988 is a clinical study titled "A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.". The purpose of the study is to determine the safety and weight loss when sibutramine is used in overweight and obese subjects.
What is the current status of trial NCT00234988?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 93 participants. The study started on 2004-06.
What interventions are being tested in trial NCT00234988?
The interventions under investigation include: sibutramine hydochloride monohydrate (DRUG).
Who is sponsoring clinical trial NCT00234988?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.